Clinical trial Recruiting at 1 site Interventional Ages 40 to 75

Coherent Breathing vs Regular Paced Breathing for COPD Dyspnea and Lung Function

Official title: Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease

Run by Foundation University Islamabad · NCT07875036 · Data updated 2026-11-12

In this study, adults with COPD test whether coherent breathing helps reduce shortness of breath and improve breathing tests compared with regular paced breathing.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment46 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Rawalpindi)
StatusRecruiting
StartedFebruary 11, 2026
Main results expectedDecember 15, 2026
Study endsDecember 15, 2026
Registry record updatedOctober 15, 2026
Trial IDNCT07875036 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40-75 with mild to moderate COPD (GOLD) diagnosed for at least 6 months, resting SpO2 ≥ 90% on room air, and able to follow instructions.

Probably not a fit

Patients with severe COPD, recent COPD exacerbation, active smoking, or other significant respiratory diseases may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares two non-drug breathing techniques in adults with mild to moderate COPD. Participants are randomized into either Coherent Breathing or Regular Paced Breathing groups and receive standard pharmacological care. Outcomes include dyspnea, pulmonary function tests, and quality of life measures. The study aims to determine if one breathing approach provides greater benefits for functional status and breathing efficiency. Enrollment targets 46 participants at Foundation University Islamabad, with specific eligibility and safety criteria.

Why it matters

Potential benefit: If successful, patients may experience reduced dyspnea and better breathing performance with a non-pharmacological, easily teachable technique.

How similar studies have gone: Breathing retraining approaches have shown potential benefits in COPD, but direct comparisons between coherent and paced breathing in this population are still emerging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 40-75 years.
* Both genders (male and females).
* Diagnosed COPD mild to moderate stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification:

Mild: FEV1 ≥ 80% predicted Moderate: FEV1 fall between 50-79%

* Diagnosed with COPD for at least 6 months prior to enrollment in study
* Resting SpO₂ ≥ 90% on room air

Exclusion Criteria:

* Severe and very severe stage of COPD according to GOLD classification
* Patients having acute exacerbation of COPD with in the last 4 weeks
* Hemodnamically unstable patients
* Current smokers (active smoking or individuals using any tobacco product within the 6 months)
* Other sgnificant respiratory diseases (e.g., asthma, bronchiectasis, ILD, active tuberculosis)
* Patients unable to follow commands/instructions
* Patients currently participating in any other structured pulmonary rehabilitation or breathing intervention program

Where it's running

  • Foundation University Islamabad
    Rawalpindi, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.